Shire News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

18.10.23	Takeda Settles Tax Dispute With Irish Revenue Commissioners Over Break Fee Received By Shire (RTTNews)
27.08.20	Shire Acq Inv Ireland Designated Activity Co -- Moody's announces completion of a periodic review of ratings of Takeda Pharmaceutical Company Limited (Moodys)
25.06.20	Shire Acq Inv Ireland Designated Activity Co -- Moody's affirms Takeda's ratings; assigns Baa2 to proposed notes (Moodys)
16.10.19	Shire Acq Inv Ireland Designated Activity Co -- Moody's announces completion of a periodic review of ratings of Takeda Pharmaceutical Company Limited (Moodys)
30.05.19	KNDL 2019-KNSQ Mortgage Trust -- Moody's assigns definitive ratings to Five CMBS classes of KNDL 2019-KNSQ Mortgage Trust (Moodys)
14.05.19	Japan's Takeda forecasts surprise annual loss on Shire-related costs (Reuters)
14.05.19	Takeda FY18 Profit Down, Revenues Climb (RTTNews)
14.05.19	Japan's Takeda forecasts 193 billion yen annual operating loss on Shire deal (Reuters)
09.05.19	Takeda To Sell Dry Eye Drug, Surgical Patch To Novartis, J&J For Up To $5.7 Bln (RTTNews)
08.05.19	KNDL 2019-KNSQ Mortgage Trust -- Moody's assigns provisional ratings to five CMBS classes of KNDL 2019-KNSQ Mortgage Trust (Moodys)
08.05.19	Moody's assigns provisional ratings to five CMBS classes of KNDL 2019-KNSQ Mortgage Trust (Moodys)
30.01.19	Equiniti Manages Settlement Of Takeda-Shire Deal - Quick Facts (RTTNews)
22.01.19	Takeda Reportedly Considers Sale Of $3 Billion In Emerging-Market Assets (RTTNews)
17.12.18	Form 8.3 - The Vanguard Group, Inc.: Shire plc (EQS Group)
17.12.18	Shire Announces FDA Approval For Motegrity - Quick Facts (RTTNews)
17.12.18	Takeda Pharmaceutical Company Limited -- Moody's downgrades Takeda to Baa2; outlook stable (Moodys)
05.12.18	Takeda clears key hurdle as investors back $59 billion Shire deal (Reuters)
05.12.18	Shire Shareholders Approve Takeda Deal - Quick Facts (RTTNews)
05.12.18	Takeda investors back $59 billion Shire deal, but wary of debt load (Reuters)
05.12.18	Takeda shareholders approve $59 billion Shire buy but are wary of debt load (Reuters)
05.12.18	Takeda Shareholders Approve Resolutions Related To Proposed Acquisition Of Shire (RTTNews)
05.12.18	Takeda shareholders give nod for $59 billion Shire acquisition (Reuters)
30.11.18	Shire Granted Marketing Authorisation In EU For TAKHZYRO - Quick Facts (RTTNews)
26.11.18	Biotech Stocks Facing FDA Decision In December (RTTNews)
16.11.18	Form 8.3 - The Vanguard Group, Inc.: Shire plc (EQS Group)
16.11.18	Shire Plc Reports Promising Data From HELP Extension Study With Lanadelumab (RTTNews)
16.11.18	Shire Announces New HELP Study(TM) Data for Lanadelumab in HAE at 2018 ACAAI Annual Scientific Meeting (GlobeNewswire)
16.11.18	Takeda Pharmaceutical Company Limited -- Moody's assigns A2 to Takeda's proposed notes; places rating under review for downgrade (Moodys)
13.11.18	Shire: FDA To Review SNDA To Extend Indication Of GATTEX - Quick Facts (RTTNews)
12.11.18	Takeda's Shire takeover to bring $963 million fee bonanza (Reuters)
09.11.18	Exclusive: Takeda to win EU approval for $62 billion Shire deal - sources (Reuters)
09.11.18	Exclusive: EU regulators to clear $62 billion Takeda, Shire deal - source (Reuters)
09.11.18	Takeda Pharmaceutical Company Limited -- Moody's assigns A2 to Takeda's proposed notes; places rating under review for downgrade (Moodys)
05.11.18	Takeda CEO confident of investor backing for $62 billion Shire deal (Reuters)
25.10.18	Shire Files Submission For FDA Approval To Manufacture Flexbumin At Georgia Site (RTTNews)
19.10.18	Shire: CHMP Recommends EU Marketing Authorisation Of Lanadelumab (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Zurich Insur Gr	582.00	3.23 %	K V
ABB	52.90	1.69 %	K V
CieFinRichemont	180.65	1.03 %	K V
Swiss Re	140.15	0.72 %	K V
Holcim	96.02	0.57 %	K V
UBS Group	30.29	-0.69 %	K V
Alcon	80.14	-1.01 %	K V
Novartis	95.58	-1.05 %	K V
Sonova Hldg	294.10	-1.21 %	K V
Roche Hldg G	290.80	-1.32 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Shire plc (Spons. ADRs)

Aktien Top/Flop

Meistgelesene Nachrichten